Search

everythinglearnresearchcommunity

for

Search:↓

The FRZB gene slows hair growth in rabbits.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

ZD1839 can cause skin issues like acne and hair changes.

Minoxidil slows down keratinocyte growth without being toxic.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Blocking BMP signaling causes hair loss and disrupts hair growth cycles.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

New treatments show promise for hair loss, especially JAK inhibitors for alopecia areata.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Extracellular ATP promotes growth, while adenosine inhibits it in Arabidopsis plants.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

BMP signaling controls hair follicle size and cell growth by affecting cell cycle genes.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Progerin affects cell shape but not hair or skin in mice.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

New treatments for PCOS are improving fertility and managing symptoms better.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.